Interest of antioxidant agents in parasitic diseases. The case study of coumarins

Current Topics in Medicinal Chemistry

Volumn 15, Issue 9, 2015, Pages 850-856

  Figueroa Guiñez, Roberto ^a   Matos, Maria João ^b,c   Vazquez Rodriguez, Saleta ^b,c   Santana, Lourdes ^b   Uriarte, Eugenio ^b   Borges, Fernanda ^c   Olea Azar, Claudio ^a   Maya, Juan Diego ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antioxidant; Coumarins; Oxidative stress; Parasitic diseases

Indexed keywords

4 HYDROXYCOUMARIN DERIVATIVE; ANTIOXIDANT; CHALCONE; COUMARIN DERIVATIVE; FLAVONOID; GLUTATHIONE PEROXIDASE; KAEMPFEROL; KAEMPFEROL 3 GALACTOSIDE; OXYGEN RADICAL; QUERCETIN; REACTIVE NITROGEN SPECIES; RHAMNETIN; SUPEROXIDE DISMUTASE; TROLOX C; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CHAGAS DISEASE; CYTOTOXICITY; DNA DAMAGE; DPPH RADICAL SCAVENGING ASSAY; ELECTRON SPIN RESONANCE; HAPLOPAPPUS; HUMAN; KINETOPLASTIDA; LARKSPUR; LEISHMANIA; MALARIA; NONHUMAN; OXIDATIVE STRESS; PARASITOSIS; PLASMODIUM; PROTOZOON; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; METABOLISM; PARASITIC DISEASES;

ANIMALS; ANTIOXIDANTS; CHAGAS DISEASE; COUMARINS; DRUG DISCOVERY; HUMANS; MOLECULAR STRUCTURE; OXIDATIVE STRESS; PARASITIC DISEASES; REACTIVE OXYGEN SPECIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84928879620     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150220113155     Document Type: Article

References (73)

1. Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. W.H.O.: Geneva, 2011
2. Maya, J.D.; Cassels, B.K.; Iturriaga-Vasquez, P.; Ferreira, J.; Faundez, M.; Galanti, N.; Ferreira, A.; Morello, A., Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp. Biochem. Physiol. A Mol. Integr. Physiol., 2007, 146, (4), 601-620
3. Zacks, M.A.; Wen, J.J.; Vyatkina, G.; Bhatia, V.; Garg, N., An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. Anais da Academia Brasileira de Ciencias. 2005, 77, (4), 695-715
4. Bubols, G.B.; Vianna Dda, R.; Medina-Remon, A.; von Poser, G.; Lamuela-Raventos, R.M.; Eifler-Lima, V.L.; Garcia, S.C., The antioxidant activity of coumarins and flavonoids. Mini-Rev. Med. Chem., 2013, 13, (3), 318-334
5. Gupta, S.; Wen, J.J.; Garg, N.J., Oxidative Stress in Chagas Disease. Interdiscip. Perspect Infect. Dis., 2009, 2009, 190354
6. Perez-Fuentes, R.; Lopez-Colombo, A.; Ordonez-Toquero, G.; Gomez-Albino, I.; Ramos, J.; Torres-Rasgado, E.; Salgado-Rosas, H.; Romero-Diaz, M.; Pulido-Perez, P.; Sanchez-Guillen, M.C., Correlation of the serum concentrations of tumour necrosis factor and nitric oxide with disease severity in chronic Chagas disease (American trypanosomiasis). Ann. Trop. Med. Parasit., 2007, 101, (2), 123-132
7. Abd Ellah, M.R., Involvement of free radicals in parasitic infestations. J Appl Anim Res, 2013, 41, (1), 69-76
8. Kocyigit, A.; Keles, H.; Selek, S.; Guzel, S.; Celik, H.; Erel, O., Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. Mutat. Res-Gen. Tox. En., 2005, 585, (1-2), 71-78
9. Olin-Sandoval, V.; Moreno-Sanchez, R.; Saavedra, E., Targeting trypanothione metabolism in trypanosomatid human parasites. Curr. Drug Targets, 2010, 11, (12), 1614-1630
10. Kayser, O.; Kiderlen, A.F.; Croft, S.L., Natural products as antiparasitic drugs. Parasitol Res. 2003, 90 Suppl 2, S55-62
11. Isah, M.B.; Ibrahim, M.A., The role of antioxidants treatment on the pathogenesis of malarial infections: a review. Parasitol Res., 2014, 113, (3), 801-809
12. Cheema, H.S.; Prakash, O.; Pal, A.; Khan, F.; Bawankule, D.U.; Darokar, M.P., Glabridin induces oxidative stress mediated apoptosis like cell death of malaria parasite Plasmodium falciparum. Parasitol. Int., 2014, 63, (2), 349-358
13. Vigueira, P.A.; Ray, S.S.; Martin, B.A.; Ligon, M.M.; Paul, K.S., Effects of the green tea catechin (-)-epigallocatechin gallate on Trypanosoma brucei. Int. J. Parasitol-Drug. 2012, 2, 225-229
14. Guida, M.C.; Esteva, M.I.; Camino, A.; Flawia, M.M.; Torres, H.N.; Paveto, C., Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg). Exp. Parasitol., 2007, 117, (2), 188-194
15. Inacio, J.D.F.; Canto-Cavalheiro, M.M.; Almeida-Amaral, E.E., In vitro and in vivo Effects of (-)-Epigallocatechin 3-O-gallate on Leishmania amazonensis. J. Nat. Prod., 2013, 76, (10), 1993-1996
16. Marin, C.; Ramirez-Macias, I.; Lopez-Cespedes, A.; Olmo, F.; Villegas, N.; Diaz, J.G.; Rosales, M.J.; Gutierrez-Sanchez, R.; Sanchez-Moreno, M., In vitro and in vivo Trypanocidal Activity of Flavonoids from Delphinium staphisagria against Chagas Disease. J. Nat. Prod., 2011, 74, (4), 744-750
17. Kerboeuf, D.; Riou, M.; Guegnard, F., Flavonoids and related compounds in parasitic disease control. Mini-Rev. Med. Chem., 2008, 8, (2), 116-128
18. dos Santos, D.A.; de, C.B.P.A.; da Silva, M.F.; Fernandes, J.B.; Vieira, P.C.; Magalhaes, A.F.; Magalhaes, E.G.; Marsaioli, A.J.; de, S.M.V.R.; Rattray, L.; Croft, S.L., Anti-African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analogues. J. Pharm. Pharmacol., 2009, 61, (2), 257-266
19. Marin, C.; Boutaleb-Charki, S.; Diaz, J.G.; Huertas, O.; Rosales, M.J.; Perez-Cordon, G.; Guitierrez-Sanchez, R.; Sanchez-Moreno, M., Antileishmaniasis activity of flavonoids from Consolida oliveriana. J. Nat. Prod., 2009, 72, (6), 1069-1074
20. Ganapaty, S.; Lakshminarayana, K.; Lakshmi, P.; Thomas, P.S., Antiprotozoal and Cytotoxicity Assays of the Isolates of Tephrosia tinctoria. Asian J. Chem., 2009, 21, (2), 1007-1010
21. Vazquez-Rodriguez, S.; Figueroa-Guinez, R.; Matos, M.J.; Santana, L.; Uriarte, E.; Lapier, M.; Maya, J.D.; Olea-Azar, C., Synthesis of coumarin-chalcone hybrids and evaluation of their antioxidant and trypanocidal properties. MedChemComm., 2013, 4, (6), 993-1000
22. Tolomeo, M.; Roberti, M.; Scapozza, L.; Tarantelli, C.; Giacomini, E.; Titone, L.; Saporito, L.; Di Carlo, P.; Colomba, C., TTAS a new stilbene derivative that induces apoptosis in Leishmania infantum. Exp. Parasitol., 2013, 133, (1), 37-43
23. Kumar, D.; Kumar, M.; Kumar, A.; Singh, S.K., Chalcone and Curcumin Derivatives: A Way Ahead for Malarial Treatment. Mini-Rev. Med. Chem., 2013, 13, (14), 2116-2133
24. Schmidt, T.J.; Khalid, S.A.; Romanha, A.J.; Alves, T.M.A.; Biavatti, M.W.; Brun, R.; Da Costa, F.B.; de Castro, S.L.; Ferreira, V.F.; de Lacerda, M.V.G.; Lago, J.H.G.; Leon, L.L.; Lopes, N.P.; Amorim, R.C.D.; Niehues, M.; Ogungbe, I.V.; Pohlit, A.M.; Scotti, M.T.; Setzer, W.N.; Soeiro, M.D.C.; Steindel, M.; Tempone, A.G., The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases - Part II. Curr. Med. Chem., 2012, 19, (14), 2176-2228
25. Ferreira, M.E.; de Arias, A.R.; Yaluff, G.; de Bilbao, N.V.; Nakayama, H.; Torres, S.; Schinini, A.; Guy, I.; Heinzen, H.; Fournet, A., Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata. Phytomedicine., 2010, 17, (5), 375-378
26. Evans, W.C.; Evans, D.; Trease, G.E. Trease and Evans pharmacognosy. 16th ed. Saunders/Elsevier: Edinburgh; New York, 2009
27. Spino, C.; Dodier, M.; Sotheeswaran, S., Anti-HIV coumarins from Calophyllum seed oil. Bioorg. Med. Chem. Lett., 1998, 8, (24), 3475-3478
28. Venugopala, K.N.; Rashmi, V.; Odhav, B., Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity. Biomed. Res. Int., 2013
29. Borges, F.; Roleira, F.; Milhazes, N.; Santana, L.; Uriarte, E., Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr. Med. Chem., 2005, 12, (8), 887-916
30. Lake, B.G., Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem. Toxicol., 1999, 37, (4), 423-453
31. Peng, X.M.; Damu, G.L.; Zhou, C., Current developments of coumarin compounds in medicinal chemistry. Curr. Pharm. Des., 2013, 19, (21), 3884-3930
32. Jackson, L.R.; Becker, R.C., Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal. J.Thromb. Thrombolys, 2014, 37, (3), 380-391
33. Carocho, M.; Ferreira, I.C.F.R., The Role of Phenolic Compounds in the Fight against Cancer - A Review. Anti Cancer Regent Me., 2013, 13, (8), 1236-1258
34. Kontogiorgis, C.; Detsi, A.; Hadjipavlou-Litina, D., Coumarinbased drugs: a patent review (2008-present). Expert Opin. Ther. Pat., 2012, 22, (4), 437-454
35. Hupfeld, J.; Efferth, T., Drug Resistance of Human Immunodeficiency Virus and Overcoming it by Natural Products. In vivo., 2009, 23, (1), 1-6
36. Patel, R.V.; Kumari, P.; Rajani, D.P.; Chikhalia, K.H., Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl/benzothiazolyl acetamides as antimicrobial and antituberculosis agents. Med. Chem. Res., 2013, 22, (1), 195-210
37. Kostova, I.; Bhatia, S.; Grigorov, P.; Balkansky, S.; Parmar, V.S.; Prasad, A.K.; Saso, L., Coumarins as antioxidants. Curr. Med. Chem., 2011, 18, (25), 3929-3951
38. Witaicenis, A.; Seito, L.N.; Chagas, A.D.; de Almeida, L.D.; Luchini, A.C.; Rodrigues-Orsi, P.; Cestari, S.H.; Di Stasi, L.C., Antioxidant and intestinal anti-inflammatory effects of plantderived coumarin derivatives. Phytomedicine., 2014, 21, (3), 240-246
39. Xi, G.L.; Liu, Z.Q., Antioxidant effectiveness generated by one or two phenolic hydroxyl groups in coumarin-substituted dihydropyrazoles. Eur. J. Med. Chem., 2013, 68, 385-393
40. Matos, M.J.; Vina, D.; Vazquez-Rodriguez, S.; Uriarte, E.; Santana, L., Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold. Curr. Top. Med. Chem., 2012, 12, (20), 2210-2239
41. Ferino, G.; Cadoni, E.; Matos, M.J.; Quezada, E.; Uriarte, E.; Santana, L.; Vilar, S.; Tatonetti, N.P.; Yanez, M.; Vina, D.; Picciau, C.; Serra, S.; Delogu, G., MAO inhibitory activity of 2- arylbenzofurans versus 3-arylcoumarins: synthesis, in vitro study, and docking calculations. ChemMedChem., 2013, 8, (6), 956-966
42. Matos, M.J.; Vilar, S.; Gonzalez-Franco, R.M.; Uriarte, E.; Santana, L.; Friedman, C.; Tatonetti, N.P.; Vina, D.; Fontenla, J.A., Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. Eur. J. Med. Chem., 2013, 63, 151-161
43. Serra, S.; Ferino, G.; Matos, M.J.; Vazquez-Rodriguez, S.; Delogu, G.; Vina, D.; Cadoni, E.; Santana, L.; Uriarte, E., Hydroxycoumarins as selective MAO-B inhibitors. Bioorg. Med. Chem. Lett., 2012, 22, (1), 258-261
44. Molina, E.; Sobarzo-Sanchez, E.; Speck-Planche, A.; Matos, M.J.; Uriarte, E.; Santana, L.; Yanez, M.; Orallo, F., Monoamino oxidase a: an interesting pharmacological target for the development of multi-target QSAR. Mini-Rev. Med. Chem., 2012, 12, (10), 947-958
45. Vina, D.; Matos, M.J.; Ferino, G.; Cadoni, E.; Laguna, R.; Borges, F.; Uriarte, E.; Santana, L., 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies. ChemMedChem., 2012, 7, (3), 464-470
46. Torres, R.; Faini, F.; Modak, B.; Urbina, F.; Labbe, C.; Guerrero, J., Antioxidant activity of coumarins and flavonols from the resinous exudate of Haplopappus multifolius. Phytochemistry., 2006, 67, (10), 984-987
47. Molnar, M.; Cacic, M., Antioxidant activity of some (7-hydroxy-2- oxo-2H-chromen-4-yl) acetic acid derivatives. Croat. J. Food Sci. Technol., 2012, 4, (1), 54-63
48. Perez-Cruz, F.; Serra, S.; Delogu, G.; Lapier, M.; Maya, J.D.; Olea- Azar, C.; Santana, L.; Uriarte, E., Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives. Bioorg. Med. Chem. Lett., 2012, 22, (17), 5569-5573
49. Matos, M.J.; Perez-Cruz, F.; Vazquez-Rodriguez, S.; Uriarte, E.; Santana, L.; Borges, F.; Olea-Azar, C., Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins. Bioorg.Med. Chem., 2013, 21, (13), 3900-3906
50. Guinez, R.F.; Matos, M.J.; Vazquez-Rodriguez, S.; Santana, L.; Uriarte, E.; Olea-Azar, C.; Maya, J.D., Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives. Future Med. Chem., 2013, 5, (16), 1911-1922
51. Perez-Cruz, F.; Vazquez-Rodriguez, S.; Matos, M.J.; Herrera- Morales, A.; Villamena, F.A.; Das, A.; Gopalakrishnan, B.; Olea- Azar, C.; Santana, L.; Uriarte, E., Synthesis and electrochemical and biological studies of novel coumarin-chalcone hybrid compounds. J. Med. Chem., 2013, 56, (15), 6136-6145
52. Folch-Cano, C.; Olea-Azar, C.; Sobarzo-Sanchez, E.; Alvarez- Lorenzo, C.; Concheiro, A.; Otero, F.; Jullian, C., Inclusion Complex of 4-Hydroxycoumarin with Cyclodextrins and Its Characterization in Aqueous Solution. J. Sol. Chem., 2011, 40, (11), 1835-1846
53. Perez-Cruz, F.; Villamena, F.A.; Zapata-Torres, G.; Das, A.; Headley, C.A.; Quezada, E.; Lopez-Alarcon, C.; Olea-Azar, C., Selected hydroxycoumarins as antioxidants in cells: physicochemical and reactive oxygen species scavenging studies. J. Phys. Org. Chem., 2013, 26, (10), 773-783
54. Guardado-Yordi, E.; Molina, E.; Matos, M.J.; Uriarte, E. In Nutrition, Well-Being and Health. Bouayed, J.; Bohn, T., Eds.; InTech: Rijeka, Croatia, 2012, pp 23-48
55. Janeiro, P.; Matos, M.J.; Santana, L.; Uriarte, E.; Oliveira-Brett, A.M., New hydroxylated 3-arylcoumarins, synthesis and electrochemical study. J. Electroanal Chem., 2013, 689, 243-251
56. Symeonidis, T.; Chamilos, M.; Hadjipavlou-Litina, D.J.; Kallitsakis, M.; Litinas, K.E., Synthesis of hydroxycoumarins and hydroxybenzo[f]- or [h]coumarins as lipid peroxidation inhibitors. Bioorg. Med. Chem. Lett., 2009, 19, (4), 1139-1142
57. Kostova, I., Synthetic and natural coumarins as antioxidants. Mini- Rev. Med. Chem. 2006, 6, (4), 365-374
58. Bailly, F.; Maurin, C.; Teissier, E.; Vezin, H.; Cotelle, P., Antioxidant properties of 3-hydroxycoumarin derivatives. Bioorgan. Med. Chem., 2004, 12, (21), 5611-5618
59. Tyagi, Y.K.; Kumar, A.; Raj, H.G.; Vohra, P.; Gupta, G.; Kumari, R.; Kumar, P.; Gupta, R.K., Synthesis of novel amino and acetyl amino-4-methylcoumarins and evaluation of their antioxidant activity. Eur. J. Med. Chem., 2005, 40, (4), 413-420
60. Hamdi, N.; Puerta, M.C.; Valerga, P., Synthesis, structure, antimicrobial and antioxidant investigations of dicoumarol and related compounds. Eur. J. Med. Chem., 2008, 43, (11), 2541-2548
61. Gliszczynska, A.; Brodelius, P.E., Sesquiterpene coumarins. Phytochem. Rev., 2012, 11, (1), 77-96
62. Panteleon, V.; Kostakis, I.K.; Marakos, P.; Pouli, N.; Andreadou, I., Synthesis and free radical scavenging activity of some new spiropyranocoumarins. Bioorg. Med. Chem. Lett., 2008, 18, (21), 5781-5784
63. Nordberg, J.; Arner, E.S.J., Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Bio. Med., 2001, 31, (11), 1287-1312
64. Melagraki, G.; Afantitis, A.; Igglessi-Markopoulou, O.; Detsi, A.; Koufaki, M.; Kontogiorgis, C.; Hadjipavlou-Litina, D.J., Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur. J. Med. Chem., 2009, 44, (7), 3020-3026
65. Symeonidis, T.; Fylaktakidou, K.C.; Hadjipavlou-Litina, D.J.; Litinas, K.E., Synthesis and anti-inflammatory evaluation of novel angularly or linearly fused coumarins. Eur. J. Med. Chem., 2009, 44, (12), 5012-5017
66. Olomola, T.O.; Klein, R.; Mautsa, N.; Sayed, Y.; Kaye, P.T., Synthesis and evaluation of coumarin derivatives as potential dualaction HIV-1 protease and reverse transcriptase inhibitors. Bioorg. Med. Chem., 2013, 21, (7), 1964-1971
67. Mao, W.W.; Wang, T.T.; Zeng, H.P.; Wang, Z.Y.; Chen, J.P.; Shen, J.G., Synthesis and evaluation of novel substituted 5- hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines. Bioorg. Med. Chem. Lett., 2009, 19, (16), 4570-4573
68. Vazquez, R.; Riyeiro, M.E.; Mondillo, C.; Perazzo, J.C.; Vermeulen, M.; Baldi, A.; Davio, C.; Shayo, C., Pharmacodynamic study of the 7,8-dihydroxy-4-methylcoumarin-induced selective cytotoxicity toward U-937 leukemic cells versus mature monocytes: Cytoplasmic p21(Cip1/WAF1) as resistance factor. Biochem. Pharmacol., 2013, 86, (2), 210-221
69. Thuong, P.T.; Hung, T.M.; Ngoc, T.M.; Ha, D.T.; Min, B.S.; Kwack, S.J.; Kang, T.S.; Choi, J.S.; Bae, K., Antioxidant Activities of Coumarins from Korean Medicinal Plants and their Structure- Activity Relationships. Phytother. Res., 2010, 24, (1), 101-106
70. Freitas, R.F.; Prokopczyk, I.M.; Zottis, A.; Oliva, G.; Andricopulo, A.D.; Trevisan, M.T.; Vilegas, W.; Silva, M.G.; Montanari, C.A., Discovery of novel Trypanosoma cruzi glyceraldehyde-3- phosphate dehydrogenase inhibitors. Bioorg. Med. Chem., 2009, 17, (6), 2476-2482
71. Menezes, I.R.A.; Lopes, J.C.D.; Montanari, C.A.; Oliva, G.; Pavao, F.; Castilho, M.S.; Vieira, P.C.; Pupo, M.T., 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi. J. Comput. Aid Mol. Des., 2003, 17, (5-6), 277-290
72. Alvim, J.; Dias, R.L.A.; Castilho, M.S.; Oliva, G.; Correa, A.G., Preparation and evaluation of a coumarin library towards the inhibitory activity of the enzyme gGAPDH from Trypanosoma cruzi. J. Brazil Chem. Soc., 2005, 16, (4), 763-773
73. Leitao, A.; Andricopulo, A.D.; Oliva, G.; Pupo, M.T.; de Marchi, A.A.; Vieira, P.C.; da Silva, M.F.; Ferreira, V.F.; de Souza, M.C.; Sa, M.M.; Moraes, V.R.; Montanari, C.A., Structure-activity relationships of novel inhibitors of glyceraldehyde-3-phosphate dehydrogenase. Bioorg. Med. Chem. Lett., 2004, 14, (9), 2199-2204.